This study evaluates the impact of patient cost sharing on the probability of receiving disease-modifying therapies and treatment compliance among patients with multiple sclerosis.
Safiya Abouzaid, PharmD
Advertisement
Articles by Safiya Abouzaid, PharmD
Advertisement
Latest Updated Articles
- Impact of Patient Cost Sharing on Multiple Sclerosis Treatment
Published: November 14th 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Recognizing Immunizing Pharmacists in the Community
2
FDA, HHS Move to Accelerate Biosimilar Approvals
3
Accelerated Approval of Cancer Drugs: Benefit or Burden?
4
Denosumab Biosimilars Conexxence and Bomyntra Receive Interchangeability Designation
5
